Civica Rx lays out $124M sterile injectables plant, pegged to supply COVID-19 drugs and more

Last spring, upstart generics maker Civica Rx joined forces with the brand-new Phlow Corp. in a push to “onshore” U.S. drug manufacturing and supply essential meds to hospitals fighting the pandemic. Now, the company is blueprinting a dedicated plant to do just that.